Study

EORTC-2029-LCG

Immunotherapy Consolidation After Radical treatment of Synchronous Oligo-metastatic NSCLC: ICARS

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 14-Jan-2025

Data management at EORTC

Yes

Design

Phase 2
Randomized blind

Treatment

Radiotherapy, Drug
Cemiplimab

Study Staff

  • Frank Aboubakar Nana (Study Coordinator), Cliniques Universitaires Saint-Luc, Brussels
  • Justine Bobinnec (Study Coordinator), EORTC Liaison Office France, Paris
  • Dirk de Ruysscher (Study Coordinator), Maastro Clinic - Maastricht Radiation Oncology, Maastricht
  • Christopher Doty (Project Manager), EORTC Headquarters, Brussels
  • Sandrine Marreaud (Clinical Research Physician), EORTC Headquarters, Brussels
  • Daniel Portik (Clinical Research Physician), EORTC Headquarters, Brussels
  • Jose Silva (Clinical Research Physician), EORTC Headquarters, Brussels
  • Anne-Sophie Govaerts (Clinical Scientist), EORTC Headquarters, Brussels
  • Luc Boone (Statistician), EORTC Headquarters, Brussels
  • Corneel Coens (Statistician), EORTC Headquarters, Brussels
  • Murielle Mauer (Statistician), EORTC Headquarters, Brussels
  • Nitish Jha (Statistical Analyst), EORTC Headquarters, Brussels
  • Emmanuelle Sidot (TR Scientist), EORTC Headquarters, Brussels
  • Boubker Ait Brik (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Sofie Verschueren (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Peter De Burghgraeve (Data Manager), EORTC Headquarters, Brussels
  • Tim Verbiest (Study Designer), EORTC Headquarters, Brussels
  • Yuliya Vostrikova (Clinical Data Expert), EORTC Headquarters, Brussels
  • Hadi Almidani (Pharmacovigilance Manager), EORTC Headquarters, Brussels
  • Anja Mestnik (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Eliza Starczewska (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Jessica Berger (Clinical Research Associate/Monitor), EORTC Headquarters, Brussels
  • Daniel Urosa (Clinical Research Associate/Monitor), EORTC Headquarters, Brussels
  • Luminita Copaceanu (Lead CRA), EORTC Headquarters, Brussels
  • Miguel Remis (Lead CRA), EORTC Headquarters, Brussels
  • Ilse Coppens (Clinical Operations Assistant), EORTC Headquarters, Brussels
  • Myrto Moutafi (Clinical Research Physician Fellow), EORTC Headquarters, Brussels
  • Volha Hertsyk (Medical Fellow), EORTC Headquarters, Brussels
  • Lotte van der Weijst (QoL Specialist), EORTC Headquarters, Brussels
  • Enrico Clementel (RTQA Manager), EORTC Headquarters, Brussels
  • Luiza Souza (RTQA Officer), EORTC Headquarters, Brussels

Type of cancer

  • Lung

Participating groups

  • EORTC Lung Cancer Group

Recruiting centers

  • AUSL Della Romagna -Ospedale Santa Maria delle Croci (Ravenna, Italy)
  • Academisch Ziekenhuis Maastricht (Maastricht, Netherlands)
  • Azienda Sanitaria Universitaria Friuli Centrale (Ospedaliero Universitario "Santa Maria della Misericordia" ) (Udine, Italy)
  • Azienda Unita Locale Socio-Sanitaria N. 9-Mater Salutis Hospital (Legnago, Italy)
  • CH de La Cote Basque - Saint Leon (Bayonne, France)
  • CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
  • CHU Mont Godinne - UCL Namur (Yvoir, Belgium)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Hospital De La Santa Creu I Sant Pau (Barcelona, Spain)
  • Hospital Quironsalud Sagrado Corazon (Sevilla, Spain)
  • Institut Paoli-Calmettes (MARSEILLE CEDEX 09, France)
  • UOMi Cancer Center (Micancer Center SLP) (Barcelona, Spain)

Centers to be activated

  • ASST Ovest Milanese-Legnano (Legnano( Milano), Italy)
  • Azienda Ospedaliera Universita delgi Studi della Campania Luigi Vanvitelli (Napoli, Italy)
  • C.H.U. Sart-Tilman (Liege, Belgium)
  • Complejo Hospitalario Universitario Insular Materno Infantil (Las Palmas de Gran Canaria, Spain)
  • Fondazione IRCCS - Policlinico San Matteo (Pavia, Italy)
  • GenesisCare Madrid, Hospital Universitario San Francisco de Asis (Madrid, Spain)
  • Groupe Hospitalier Paris Saint-Joseph - Hopital Saint Joseph (Paris, France)
  • Hospital Universitario Infanta Leonor (Madrid, Spain)
  • Hospital Universitario Virgen De La Victoria (Malaga, Spain)
  • Hospital Universitario de La Princesa (Madrid, Spain)
  • IMOR Institut Medic Onco-Radioterapia (Barcelona, Spain)
  • Institut Jules Bordet (Anderlecht, Belgium)
  • Istituto Clinico Humanitas (Rozzano, Milano, Italy)
  • Rijnstate Hospital (Arnhem, Netherlands)
  • University Hospital Virgen del Rocio (Sevilla, Spain)

Protocol summary

http://clinicaltrials.gov/study/NCT06219317

NCT number

NCT06219317